Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 3/20 | 0.52 |
| ▸ | GSK3B | P49841 | 3/20 | 0.52 |
| ▸ | MGLL | Q99685 | 10/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | WRN | Q14191 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 4/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11955666 | 0.81 | GSK3A (0.55) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL1103791 | 0.79 | GSK3A (0.48) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL13323652 | 0.77 | GSK3A (0.52) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL2544468 | 0.74 | ALDH1A1 (0.53) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL515800 | 0.73 | PTGS1 (0.52) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL15235652 | 0.73 | GSK3A (0.57) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL10672559 | 0.72 | GSK3A (0.47) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL28353956 | 0.71 | GSK3A (0.50) | GSK3AGSK3BMGLLALDH1A1BLM | |
| Hydrochloric Acid SCHEMBL28991159 | 0.71 | PTGS1 (0.50) | GSK3AGSK3BMGLLALDH1A1BLM | |
| SCHEMBL8010430 | 0.71 | GSK3A (0.50) | GSK3AGSK3BMGLLALDH1A1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153581-B2 | Process for producing an injectable medicament preparation | KTB TUMORFORSCHUNGS GMBH (DE) | 2012-04-10 | — | — | US | disclosed |
| US-20100215574-A1 | PROCESS FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION | Vergell Medical S.A. (CH) | 2010-08-26 | — | — | US | disclosed |
| US-7445764-B1 | Carrier-drug conjugate | KTB TUMORFORSCHUNGSGESELLSSCHAFT MBH (DE) | 2008-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215574-A1 | PROCESS FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION | MMP1, MMP2, DNPEP | GSK3A 4830/4885GSK3B 4846/4885MGLL 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.